Back to top
more

OrganiGram (OGI)

(Delayed Data from NSDQ)

$1.86 USD

1.86
752,410

0.00 (0.00%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $1.87 +0.01 (0.54%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for OGI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Organigram Holdings Inc falls in the month of September.

All items in Millions except Per Share data.

9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019
Assets          
Cash & Equivalents 25 78 78 145 56
Receivables 22 36 36 17 13
Notes Receivable 0 0 0 0 0
Inventories 60 54 54 39 53
Other Current Assets 8 7 7 5 5
Total Current Assets 116 174 174 206 127
Net Property & Equipment 73 204 204 186 184
Investments & Advances 24 27 27 29 11
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 4 4 3 1
Intangibles 8 44 44 13 1
Deposits & Other Assets 0 0 0 0 0
Total Assets 221 454 454 437 324
Liabilities & Shareholders Equity 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019
Notes Payable 0 0 0 0 0
Accounts Payable 15 32 32 18 13
Current Portion Long-Term Debt 0 0 0 0 9
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 1 1 0 0
Other Current Liabilities 2 10 10 2 0
Total Current Liabilities 17 43 43 21 22
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 3 3 0 8
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 77
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 3 8 8 38 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 20 54 54 59 101
Shareholders Equity 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 576 605 605 576 313
Capital Surplus 0 0 0 0 0
Retained Earnings -399 -228 -228 -217 -108
Other Equity 25 22 22 19 18
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 201 399 399 378 223
Total Liabilities & Shareholder's Equity 221 454 454 437 324
Total Common Equity 201 399 399 378 223
Shares Outstanding 81.10 78.40 74.90 48.60 39.00
Book Value Per Share 2.48 5.09 5.33 7.79 5.71

Fiscal Year End for Organigram Holdings Inc falls in the month of September.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 31 25 39 39
Receivables NA 21 22 27 27
Notes Receivable NA 0 0 0 0
Inventories NA 60 60 60 60
Other Current Assets NA 6 8 7 7
Total Current Assets NA 118 116 133 133
Net Property & Equipment NA 72 73 81 81
Investments & Advances NA 21 24 27 27
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 1 0 2 2
Intangibles NA 8 8 13 13
Deposits & Other Assets NA 0 0 0 0
Total Assets NA 220 221 257 257
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 26 15 25 25
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 1 2 4 4
Total Current Liabilities NA 28 17 29 29
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 2 2
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 3 3 3
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 30 20 34 34
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 571 576 571 571
Capital Surplus NA 0 0 0 0
Retained Earnings NA -407 -399 -372 -372
Other Equity NA 26 25 24 24
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 189 201 222 222
Total Liabilities & Shareholder's Equity NA 220 221 257 257
Total Common Equity 0 189 201 222 222
Shares Outstanding 103.20 94.00 81.10 80.50 78.50
Book Value Per Share 0.00 2.01 2.48 2.76 2.83